dose-finding
Showing 1 - 25 of >10,000
Long COVID Trial (Lithium)
Not yet recruiting
- Long COVID
- Lithium
- (no location specified)
Oct 27, 2023
Drug Effect Trial in Seoul (Remimazolam besylate)
Not yet recruiting
- Drug Effect
- Remimazolam besylate
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 3, 2023
Heart Failure Trial (Placebo, XXB750 Low dose, XXB750 Medium Dose)
Not yet recruiting
- Heart Failure
- Placebo
- +4 more
- (no location specified)
Nov 24, 2023
Contraception Trial in Berlin (MR-130A-01 Transdermal patch)
Recruiting
- Contraception
- MR-130A-01 Transdermal patch
-
Berlin, Germanydinox GmbH
Sep 15, 2023
Hemodynamic Instability, Tracheal Intubation, Dexmedetomidine Trial in Karachi (Normal saline, Dexmedetomidine 0.5 microgram/kg,
Completed
- Hemodynamic Instability
- +2 more
- Normal saline
- +2 more
-
Karachi, Sindh, PakistanSyed Muhammad Abbas
Jun 9, 2023
COVID-19 Trial in Yogyakarta (AdimrSC-2f)
Active, not recruiting
- COVID-19
- AdimrSC-2f
-
Yogyakarta, IndonesiaUniversity Gadjah Mada Academic Hospital
Jan 6, 2023
Hyperphosphatemia Patients on Hemodialysis Trial in Tokyo (TS-172 10mg bid, TS-172 30mg bid, TS-172 60mg bid)
Not yet recruiting
- Hyperphosphatemia Patients on Hemodialysis
- TS-172 10mg bid
- +4 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 23, 2023
Transcranial Direct Current Stimulation, Dementia Trial in Kaohsiung (DAOIB)
Suspended
- Transcranial Direct Current Stimulation
- Dementia
-
Kaohsiung, TaiwanKaohsiung Chang Gung Memorial Hospital
Oct 13, 2022
Postpartum Hemorrhage, Twin Trial in Toronto (Carbetocin)
Recruiting
- Postpartum Hemorrhage
- Twin
-
Toronto, Ontario, CanadaMount Sinai Hospital
Nov 17, 2022
Solid Advanced Tumor, Lymphoma Trial in Belgium, France (OSE-279 100mg, OSE-279 300mg, OSE-279 500mg)
Recruiting
- Solid Advanced Tumor
- Lymphoma
- OSE-279 100mg
- +2 more
-
Anderlecht, Belgium
- +5 more
Feb 27, 2023
Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)
Not yet recruiting
- Newly Diagnosed Glioblastoma
- [177Lu]Lu-NeoB
- +2 more
- (no location specified)
Feb 13, 2023
Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)
Active, not recruiting
- Myeloproliferative Neoplasm
- +4 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023
Procedural Anxiety Trial in New York (Intranasal midazolam)
Recruiting
- Procedural Anxiety
- Intranasal midazolam
-
New York, New YorkNewYork Presbyterian Morgan Stanley Children's Hospital
Oct 10, 2022
Ovarian Cancer, Hyperthermic Intraperitoneal Chemo, Paclitaxel Trial in Guangzhou (Hyperthermic Intraperitoneal Paclitaxel
Recruiting
- Ovarian Cancer
- +2 more
- Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
-
Guangzhou, Other (Non U.s.), ChinaSun Yat-sen Memorial Hospital
Nov 11, 2022
Out-Of-Hospital Cardiac Arrest, Healthy Trial in Ann Arbor (Intranasal insulin)
Completed
- Out-Of-Hospital Cardiac Arrest
- Healthy
- Intranasal insulin
-
Ann Arbor, MichiganUniversity of Michigan
Oct 13, 2022
General Anesthesia Trial in Salt Lake City (HSK3486, Propofol, Placebo)
Recruiting
- General Anesthesia
- HSK3486
- +2 more
-
Salt Lake City, UtahICON (LPRA) - Salt Lake
Nov 7, 2022
Respiratory Syncytial Virus Infections Trial in Hakata, Sumida, Kumamoto (VN-0200)
Recruiting
- Respiratory Syncytial Virus Infections
- VN-0200
-
Hakata, Fukuoka, Japan
- +2 more
Oct 27, 2022
Coronavirus Trial in Oxford (SARS-CoV-2 virus)
Recruiting
- Coronavirus
- SARS-CoV-2 virus
-
Oxford, Oxon, United Kingdom
- +2 more
Jan 5, 2023
Bone Cancer, Bone Tumor, Solid Tumor Trial in United States (153-Sm-DOTMP (Samarium-153-DOTMP))
Recruiting
- Bone Cancer
- +4 more
- 153-Sm-DOTMP (Samarium-153-DOTMP)
-
Chicago, Illinois
- +3 more
Aug 18, 2023
Hyperthermic Intraperitoneal Chemo Trial in Guangzhou (Docetaxel)
Recruiting
- Hyperthermic Intraperitoneal Chemotherapy
-
Guangzhou, Other (Non U.s.), ChinaSun Yat-sen Memorial Hospital
Jun 6, 2022
Glioblastoma Trial in Aarhus (Escalated proton therapy)
Not yet recruiting
- Glioblastoma
- Escalated proton therapy
-
Aarhus, DenmarkDanish Center for Particle Therapy
Mar 2, 2023